CTY

City Therapeutics, Inc. - Common Stock (CTY)

About City Therapeutics, Inc. - Common Stock (CTY)

City Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the development of RNAi therapeutics. The company was founded by John Maraganore, Sebastian Trousil, Ari Nowacek, Mark Keating, Kotaro Nakanishi, Yukihide Tomari, and Phillip Zamore on July 17, 2023 and is headquartered in Cambridge, MA.

Details

Daily high

$21.50

Daily low

$20.01

Price at open

$21.44

52 Week High

$23.88

52 Week Low

$18.00

Market cap

1.1B

Dividend yield

Volume

558,657

Avg. volume

569,597

P/E ratio

City Therapeutics, Inc. - Common Stock News